PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31245925-4	2019	For this nanodrug (EA-AB), an epidermal growth factor receptor (EGFR) inhibitor erlotinib (EB) is loaded into AuNCs, which are then capped and functionalized by biocompatible AuCluster@BSA (BSA = bovine serum albumin) conjugates via electrostatic interaction.	Erlotinib Hydrochloride	80-89	albumin	Homo sapiens	203-216	
31245925-4	2019	For this nanodrug (EA-AB), an epidermal growth factor receptor (EGFR) inhibitor erlotinib (EB) is loaded into AuNCs, which are then capped and functionalized by biocompatible AuCluster@BSA (BSA = bovine serum albumin) conjugates via electrostatic interaction.	Erlotinib Hydrochloride	91-93	albumin	Homo sapiens	203-216	
28268137-4	2017	An efficient method is developed for the conjugation of erlotinib analogue-4, alcohol compound, with protein, bovine serum albumin (BSA), via succinic acid linker.	Erlotinib Hydrochloride	56-65	albumin	Homo sapiens	117-130	
26952513-0	2016	Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.	Erlotinib Hydrochloride	120-129	albumin	Homo sapiens	0-13	
26952513-3	2016	The aim of our retrospective study was to evaluate the association of baseline serum albumin with outcomes in a large cohort of patients with advanced-stage NSCLC treated with erlotinib.	Erlotinib Hydrochloride	176-185	albumin	Homo sapiens	79-92	
22615615-0	2010	Spectroscopic studies on the interaction between erlotinib hydrochloride and bovine serum albumin.	Erlotinib Hydrochloride	49-72	albumin	Homo sapiens	84-97	
23072300-1	2013	The purpose of this study was to investigate the site-selective binding of erlotinib hydrochloride (ET), a targeted anticancer drug, to bovine serum albumin (BSA) through 1H NMR, spectroscopic, thermodynamic, and molecular modeling methods.	Erlotinib Hydrochloride	75-98	albumin	Homo sapiens	143-173	
23072300-1	2013	The purpose of this study was to investigate the site-selective binding of erlotinib hydrochloride (ET), a targeted anticancer drug, to bovine serum albumin (BSA) through 1H NMR, spectroscopic, thermodynamic, and molecular modeling methods.	Erlotinib Hydrochloride	100-102	albumin	Homo sapiens	143-173	
22615615-2	2010	In the present study, the mutual interaction of anticancer drug erlotinib hydrochloride with bovine serum albumin (BSA) using fluorescence and UV/vis spectroscopy was investigated.	Erlotinib Hydrochloride	64-87	albumin	Homo sapiens	100-113	
35209054-1	2022	The interaction between erlotinib (ERL) and bovine serum albumin (BSA) was studied in the presence of quercetin (QUR), a flavonoid with antioxidant properties.	Erlotinib Hydrochloride	24-33	albumin	Homo sapiens	51-64	
35209054-1	2022	The interaction between erlotinib (ERL) and bovine serum albumin (BSA) was studied in the presence of quercetin (QUR), a flavonoid with antioxidant properties.	Erlotinib Hydrochloride	35-38	albumin	Homo sapiens	51-64